PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit News-Medical.net The PARADIGM-HF trial has been stopped early for a benefit to patients that was overwhelmingly statistically significant. In the largest ever study of a heart failure treatment, LCZ696 won a head to head comparison with gold standard treatment and ... |
